Please Wait
Applying Filters...
menu
    • menu
    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Carbetocin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101
    Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101

    13 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230613838233/en

    BUSINESSWIRE
    13 Jun 2023
    Share Share
    Abbott introduces single-dose carbetocin for prevention of PPH in India
    Abbott introduces single-dose carbetocin for prevention of PPH in India

    31 Aug 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142217&sid=2

    PHARMABIZ
    31 Aug 2021
    Share Share
    Levo Therapeutics Announces Top-line Results from Ph3 CARE-PWS Study of LV-101
    Levo Therapeutics Announces Top-line Results from Ph3 CARE-PWS Study of LV-101

    06 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200806005540/en/Levo-Therapeutics-Announces-Top-line-Results-Phase-3

    BUSINESSWIRE
    06 Aug 2020
    Share Share
    Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum
    Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum

    13 May 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/swissmedic-approves-carbetocin-ferring-for-the-prevention-of-postpartum-haemorrhage-in-all-births-/?s=85

    BIOSPACE
    13 May 2020
    Share Share
    Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum
    Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum

    12 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200513005290/en

    BUSINESSWIRE
    12 May 2020
    Share Share
    Levo Therapeutics Receives Fast Track Designation for Prader-Willi Syndrome
    Levo Therapeutics Receives Fast Track Designation for Prader-Willi Syndrome

    19 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/levo-therapeutics-receives-fast-track-designation-from-fda-for-intranasal-carbetocin-for-the-treatment-of-prader-willi-syndrome-300959646.html

    PR NEWSWIRE
    19 Nov 2019
    Share Share